Navigation Links
Spine-Tract Anterior Lumbar Retractor System

ProductsSpine-Tract Anterior Lumbar Retractor System
Company OMNI-TRACT SURGICAL
Item Spine-Tract Anterior Lumbar Retractor System
Features Frame system sets up in seconds for anterior or anterolateral approaches. Frame arms can be positioned independently and in a low profile. Blades are adjusted independently for precise pressure and angle. Radiolucent blades eliminate the need for retractor removal during fluoroscopy. Radiolucent Wylie blades atraumatically retract the great vessels.
Description Radiolucent Retractors for image dependent spinal procedures. Excellent spinal exposure on large patients. C-Arm compatibility for outstanding exposure during image guided anterior spinal instrumentation. May be accessorized for use in anterior cervical approaches. Ideally suited for: ALIF procedures.
Info OMNI-TRACT SURGICAL
Customer Service: (800) 367-8657

Related medicine products :

1. Spine-Tract Posterior Lumbar Retractor System
2. Knolle Lens Nucleus Spatula and Anterior Chamber Gauge
3. Anterior Chamber Needle, 20 g. Angled
4. Anterior Chamber Needle, 23 g. Angled
5. Anterior Chamber Needle, 25 g. Angled
6. Anterior Chamber Needle, 30 g. Angled
7. Anterior Chamber Needle, 27 g. Angled
8. Anterior Chamber Needle, 21 g
9. Anterior Chamber Needle, 27 g
10. Anterior Stromal Puncture Cannula, 25 g
11. Anterior Chamber Irrigating Cannula
The Coreograft PLIF Allograft System is a wedge shaped, cortical strut designed to provide anterior column support and facilitate interbody fusion. This system includes a specially designed instrumen
Duet Lumbar Allografts are comprised of a raised cancellous inner core providing biomechanical properties for rapid healing. Specially designed instruments facilitate the insertion of Duet Allografts
VG2 PLIF Allograft is comprised of two cortical planks of bone surrounding a cancellous center. The cortical planks provide strength for anterior column support. The cancellous bone provides a lattic
Ramp allograft is machined from cortical bone to combine column support. The graft is machined with a textured surface for increased stability and resistance to graft migration. This allograft can be
Medicine Products:
(Date:7/25/2008)...troviral therapy may be due to genetic factors , ...ew study challenges the long-held belief that the ...s ability to restore itself after HIV patients are... (HAART). , From 50 percent to 90 percent of HI...Intravenous drug use is the main cause of both typ...
(Date:7/25/2008)...eaconEquity.com announces the,availability of Trad...can view all of the daily trading notes for free b...Trade Alerts include: DUSA Pharmaceuticals Inc. (N...Nasdaq: MBRK ), NovaMed Inc. (Nasdaq:,NOVA), Adol...: AFFX ) and,Abaxis Inc. (Nasdaq: ABAX )., Join...
(Date:7/25/2008)...ficant Improvements in Members, Health, ATLANTA, ...in health,care quality management solutions for he...ntered into a long-term agreement with Wellmark, I...n on Quality(SM) Incent and,Reward Best Practices ...rimary care clinicians to promote improved quality...
(Date:7/25/2008)...wire/ -- AutoGenomics, Inc. today,announced that i...ith the,Securities and Exchange Commission relatin...s of its common stock. The number of shares of com... to be offered by,AutoGenomics, Inc., and the pric...ined., J.P. Morgan Securities Inc. is acting as s...
Breaking Medicine News(10 mins):Health News:Study Disproves Belief That Hepatitis C Blunts HIV Drugs 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 2Health News:BeaconEquity.com Issues Technical Trade Alerts on Healthcare/Pharmaceutical Stocks: DUSA, MBRK, NOVA, ADLR, AFFX, ABAX 3Health News:MDdatacor Extends Contract with Wellmark, Inc. 2Health News:MDdatacor Extends Contract with Wellmark, Inc. 3Health News:AutoGenomics, Inc. Files Registration Statement for Initial Public Offering 2
...nts receiving highly active anti-retroviral therap...m a break in the treatment, according to new resea...cations for HIV could be better off if they took b...s could mean substantial cost savings for patients...
...ding to a research conducted by the Department of ... high amount of caffeine intake resulted in dizzin...th department has issued strong warning to public ...ne. Even coffee shops in their menu cards have in...
...tibiotic injection used to treat bacterial infecti...alth following reports of adverse drug reaction// ...pany in the eastern province of Anhui has reported...girl from Harbin. The girl suffering from common ...
...ia continues to be a killer in Assam with 275 deat...ent years, parliament was told Friday.// Minister...akshmi said in a written reply in the Rajya Sabha ...690 people had died during the last six years star...
Other Medicine News:
(Date:7/24/2008)...RLEANS, July 24 /PRNewswire-USNewswire/ -- There a...mental illnesses, according to a new,report releas...e,devastating effects that mental illnesses have o...e, mental illness affects nearly 60 million Americ... Research and Manufacturers,of America (PhRMA), fe...
(Date:7/24/2008)...ORK, July 24 /- MacroChem C...ced results of a Phase 2 clinical trial,involving ...nter,open-label efficacy and safety study of EcoN...t of onychomycosis (nail fungus). The composite,pr... cure" defined as,negative mycology (negative fung...
(Date:7/23/2008)...LE, July 23 /- Sound Pharmaceuticals ...ation with the FDA for the clinical,testing of a p...on of,chemotherapy induced hearing loss or ototoxi...5, will be tested in advanced stage lung cancer,an... based chemotherapy.,This marks the second develop...
(Date:7/23/2008)...RANCISCO, July 23 /- InCode BioPharma...ny, today announced preclinical test,results demon...rC3-1 for,the treatment of the rare chronic blood .... The complete results will be presented at the XX...tzerland, September 28,2008., The only treatment...
Breaking Medicine Technology:More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 2MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 3MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 4MacroChem Announces Phase 2 Data for EcoNail(R) in the Treatment of Onychomycosis 5Sound Pharmaceuticals Files Second IND with the FDA for the Prevention of Chemotherapy Induced Hearing Loss in Advanced Stage Cancer 2InCode BioPharmaceutics, Inc. Announces Key Data Supporting New Treatment of Paroxysmal Nocturnal Hemoglobinuria (PNH) 2Schering Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter Full Year Financial Result 2393 1Schering Plough Schedules Conference Call and Webcast for 2007 Fourth Quarter Full Year Financial Result 2393 2FOXO factor promotes survival of oxygen deprived cancer cells 8854 1FOXO factor promotes survival of oxygen deprived cancer cells 8854 2New research tools are too complex for easy answers researchers say 8852 1New research tools are too complex for easy answers researchers say 8852 2New research tools are too complex for easy answers researchers say 8852 3Copy number variation may stem from replication misstep 1735 1Copy number variation may stem from replication misstep 1735 2Copy number variation may stem from replication misstep 1735 3
...S WIRE)--Jul 5, 2007 - GTC,Biotherapeutics, Inc. (... Cox, Ph.D., GTC,s Chairman and CEO, is scheduled .... during the C.E.,Unterberg, Towbin Emerging Growt... being held at the Mandarin Oriental Hotel, New,Yo...ation will be webcast live and can be accessed by,...
... WIRE)--Jul 2, 2007 - Tercica, Inc.,(NASDAQ:TRCA) ...an,investment community presentation at the C.E. U...ference at the Mandarin Oriental,Hotel in New York...time (1:00 p.m. Pacific time)., A live audio webca...e Internet by visiting the Investors section of th...
Other Medicine Technology:GTC Biotherapeutics to Webcast Corporate Presentation at the C.E.,Unterberg, Towbin Emerging Growth Life Opportunities Conference 2